Behavioural Pharmacology Group, Laboratory of Animal Health, State University of North Fluminense, Avenida Alberto Lamego, 2000, Campos dos Goytacazes, 28013-600, RJ, Brazil.
Psychopharmacology (Berl). 2010 Apr;209(2):137-51. doi: 10.1007/s00213-009-1768-0. Epub 2010 Feb 23.
In the study of behavioural sensitization induced by dopamine agonists, D1 and D2 receptors have a critical, but a puzzling role.
The objective of this study is to examine the effects of the D1 antagonist SCH-23390 and the D2 antagonist sulpiride given repeatedly alone or in combination with apomorphine upon apomorphine conditioning and sensitization.
Apomorphine-induced (2.0 mg/kg) conditioning and sensitization were assessed following five paired/unpaired treatments. Sulpiride (10, 30 and 100 mg/kg) and SCH-23390 (0.01, 0.02 and 0.05 mg/kg) were administered alone or in combination with apomorphine. In experiment 1, the effect of 5 days of sulpiride and SCH-23390 treatments given alone were assessed on apomorphine reactivity. In experiment 2, sulpiride and SCH-23390 were co-administered with apomorphine for 5 days and subsequently, conditioning and sensitization tests were performed. In experiment 3, following five apomorphine treatment sessions, sulpiride and SCH-23390 were administered prior to the conditioning and sensitization tests.
SCH-23390 and sulpiride induced hyper-reactivity to apomorphine. SCH-23390 when given after the induction of apomorphine sensitization, blocked the expression of apomorphine sensitization. When given in combination with apomorphine, SCH-23390 blocked the apomorphine conditioning and sensitization, whereas low-dose sulpiride permitted conditioning and enhanced apomorphine sensitization and high-dose sulpiride blocked conditioning but permitted apomorphine sensitization. Both sulpiride doses transformed apomorphine sensitization from context-specific to context-independent sensitization.
The SCH-23390 findings are supportive of a critical role for D1 receptors in apomorphine effects whereas the sulpiride effects diminish the importance of conditioning and dopamine autoreceptor subsensitivity mechanisms in the mediation of apomorphine sensitization.
在多巴胺激动剂诱导的行为敏感化研究中,D1 和 D2 受体具有关键但令人费解的作用。
本研究旨在检查 D1 拮抗剂 SCH-23390 和 D2 拮抗剂舒必利单独重复给药或与阿扑吗啡联合给药对阿扑吗啡条件作用和敏感化的影响。
在五次配对/非配对处理后,评估阿扑吗啡诱导(2.0mg/kg)的条件作用和敏感化。舒必利(10、30 和 100mg/kg)和 SCH-23390(0.01、0.02 和 0.05mg/kg)单独或与阿扑吗啡联合给药。在实验 1 中,评估了单独给予舒必利和 SCH-23390 5 天治疗对阿扑吗啡反应性的影响。在实验 2 中,舒必利和 SCH-23390 与阿扑吗啡共同给药 5 天,然后进行条件作用和敏感化测试。在实验 3 中,在五次阿扑吗啡处理后,在条件作用和敏感化测试之前给予舒必利和 SCH-23390。
SCH-23390 和舒必利诱导阿扑吗啡反应过度。SCH-23390 在阿扑吗啡敏感化诱导后给予时,阻断了阿扑吗啡敏感化的表达。当与阿扑吗啡联合给予时,SCH-23390 阻断了阿扑吗啡的条件作用和敏感化,而低剂量舒必利允许条件作用并增强了阿扑吗啡敏感化,高剂量舒必利阻断了条件作用但允许阿扑吗啡敏感化。两种舒必利剂量都将阿扑吗啡敏感化从情境特异性转变为情境独立性敏感化。
SCH-23390 的发现支持 D1 受体在阿扑吗啡作用中的关键作用,而舒必利的作用降低了条件作用和多巴胺自受体敏感性机制在介导阿扑吗啡敏感化中的重要性。